· Unveils Report on New Era of BRICS: Horizons in Tech and Business for Women Empowerment in BRICS countries

· Hosts Convocation of the first batch..

The Gambia's parliament on Monday began examining a highly controversial bill on lifting a ban on female genital mutilation (FGM) in force since 2015. The issue..

On 5 December 2023, the Copyright Office which is part of the National Centre of Arts and Culture conducted a training session in The Gambia's North Bank..

India is a unicorn. Change here starts at a billion people. The countrys digital transformation journey, marked by initiatives like Aadhaar and UPI have proven..

*Riyadh, Saudi Arabia*

· DCO Member States call for multilateral, multistakeholder, and multi-sectorial digital cooperation to drive sustainable,..

Tests of a cough syrup linked to deaths in Cameroon found quality issues in one of the samples from Riemann Labs. The deaths of 141 children in Gambia,..

SRM University-AP organised an exclusive gathering of diplomats, academicians, and policy leaders from across the globe at the "*Diplomatic Exchange: Building..

The four substandard products were identified in the Gambia and reported to the WHO in September 2022.

The Uzbek health ministry stated that 18 youngsters who died had taken the cough medicine Doc-1 Max, which is produced by Noida-based Marion Biotech.

The Health Ministry of Uzbekistan has issued a statement stating that the children who died had consumed cough syrup Dok-1 Max - manufactured by Noida-based..

The investigations started after an unidentified male was found on the TUI Airways plane flying to London's Gatwick airport from Gambia's Capital, Banjul,..

WHO said that they drew a "premature link" between the deaths of children in Gambia to the Indian pharmaceutical companies who sold cough syrup.

Drugs Controller General of India (DCGI) Dr V G Somani said a statement issued by WHO in October in the wake of the deaths "was unfortunately amplified by the..

Infosys founder, Narayan Murthy says that the death of children in Gambia due to Indian cough syrup brings shame to the country.

In October, WHO had issued a medical product alert for four contaminated medicines identified in Gambia.

Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough..

The committee set up by the government to examine reports potentially linking the death of 66 children in The Gambia to four made-in-India cough syrups has..

The body said it had shut production in the manufacturing units of the company days.

Gambia child death case: The  World Health Organisation has issued alerts of India-made Maiden Pharmaceuticals Limited cough syrup "potentially linked with..

The WHO shared a detailed report on the deaths of 66 children, and the Center has assembled a four-person panel to investigate it.

Foreign minister S Jaishankar spoke to his Gambian counterpart Mamadou Tangara on Thursday and conveyed India's deepest condolences on the deaths of children..

The Centre on Wednesday formed a four-member committee to examine details and 'adverse event' reports received from the WHO on the deaths of 66 children in..

The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".

The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".

LHI: The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the..

Earlier on Monday, the Indian Pharma company had released a statement over the reports linking its cough syrups to the deaths of 66 children in Gambia.  

The suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.

The drug regulators have obtained samples of cold and cough medicine from Maiden Pharmaceuticals in response to a WHO medical alert.

Maidan Pharma has said that it has been 'obtaining raw materials from certified and reputed companies'.

Central Drugs Standard Control Organisation (CDSCO) launched an inquiry and alerted Haryana last week after learning about the Gambia tragedy.

The Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold..

In a recent advisory, WHO revealed how many children in the Gambia died due to ingesting cough syrup to get rid of their bad throats.

None of the four drugs potentially linked to the death of 66 children in Gambia are being sold in India currently, the Union health ministry has clarified...

In Today DNA, Zee News' Rohit Ranjan will analyse WHO’s global alert over four cough syrups manufactured by an India-based pharmaceutical firm that could be..

The WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.

India's drug regulator, meanwhile, has launched a probe into WHO's allegations.

The WHO has issued a medical product alert for four contaminated medicines identified in the West African country that has been potentially linked to acute..

The CDSCO said it responded to the WHO within an hour-and-a-half after receiving intimation.

The WHO on Wednesday issued a medical product alert on four ‘cough & cold’ syrups made by an Indian pharmaceutical firm — Maiden Pharmaceuticals Ltd,..

WHO said it is conducting further investigation with the Indian company and regulatory authorities in India.

The World Health Organization (WHO) on Wednesday issued a medical product alert on four cough and cold syrups made by India's Maiden Pharmaceuticals Ltd,..